SS Innovations International, Inc.
$4.85
▲
3.09%
2026-04-21 09:36:01
ssinnovations.com
NCM: SSII
Explore SS Innovations International, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$971.12 M
Current Price
$4.85
52W High / Low
$22.42 / $3.02
Stock P/E
—
Book Value
$0.2
Dividend Yield
—
ROCE
-17.08%
ROE
-46.94%
Face Value
—
EPS
$-0.06
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
483
Beta
1.91
Debt / Equity
37.57
Current Ratio
1.86
Quick Ratio
1.21
Forward P/E
—
Price / Sales
20.26
Enterprise Value
$846.89 M
EV / EBITDA
-118.98
EV / Revenue
19.93
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Cerus Corporation | $2.05 | — | $397.8 M | — | -7.17% | -25.66% | $2.96 / $1.15 | $0.33 |
| 2. | Bio-Rad Laboratories, Inc. | $302.22 | 10.88 | $8.04 B | — | 2.17% | 10.84% | $343.12 / $211.43 | $276.16 |
| 3. | Aethlon Medical, Inc. | $2.39 | — | $3.67 M | — | -171.08% | -2.09% | $35.2 / $1.36 | $6.9 |
| 4. | Myomo, Inc. | $0.9 | — | $34.65 M | — | -47.54% | -86.24% | $4.99 / $0.6 | $0.3 |
| 5. | TriSalus Life Sciences, Inc. | $4.6 | — | $285.58 M | — | -113.07% | 131.29% | $7.95 / $3.42 | $-0.68 |
| 6. | QuidelOrtho Corporation | $12.89 | — | $877.57 M | — | 1.14% | -46.15% | $38.99 / $11.61 | $28.28 |
| 7. | Owlet, Inc. | $5.82 | — | $163.61 M | — | -19.96% | -8.02% | $16.94 / $3.08 | $0.71 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 14.53 M | 12.83 M | 10 M | 5.12 M | 5.62 M | — |
| Operating Profit | -0.73 M | -1.84 M | 0.1 M | -5.92 M | -7.63 M | — |
| Net Profit | -2.47 M | -3.72 M | -0.26 M | -5.68 M | -7.45 M | — |
| EPS in Rs | -0.01 | -0.02 | -0 | -0.03 | -0.04 | -0.02 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 42.48 M | 20.65 M | 5.88 M | 1.44 M |
| Operating Profit | -8.19 M | -18.98 M | -20.27 M | -2.96 M |
| Net Profit | -12.13 M | -19.15 M | -20.88 M | -3.21 M |
| EPS in Rs | -0.06 | -0.1 | -0.1 | -0.02 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 74.23 M | 42.39 M | 31.52 M | 6.98 M |
| Total Liabilities | 36.01 M | 28.93 M | 11.8 M | 9.66 M |
| Equity | 38.22 M | 13.46 M | 19.72 M | -2.68 M |
| Current Assets | 48.8 M | 27.42 M | 21.43 M | 4.1 M |
| Current Liabilities | 26.24 M | 21.33 M | 8.47 M | 7.77 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -18.54 M | -9.5 M | -15.36 M | -5.99 M |
| Investing CF | -3.66 M | -0.66 M | -0.45 M | 0.24 M |
| Financing CF | 26.17 M | 9.43 M | 22.8 M | 5.9 M |
| Free CF | -22.2 M | -10.16 M | -15.81 M | -5.99 M |
| Capex | -3.66 M | -0.66 M | -0.45 M | -0.22 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 251.46% | 309.1% | — | — |
| Earnings Growth % | 8.27% | -549.63% | — | — |
| Profit Margin % | -92.74% | -355.36% | -223.79% | — |
| Operating Margin % | -91.9% | -345.07% | -206.01% | — |
| Gross Margin % | 40.93% | 12.35% | 4.22% | — |
| EBITDA Margin % | -85.92% | -337.53% | -198.57% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.